Myron Z Holubiak's Net Worth

$1.37 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Myron Z Holubiak?

Myron Z Holubiak has an estimated net worth of $1.37 Million. This is based on reported shares across multiple companies, which include NASTECH PHARMACEUTICAL CO INC, Citius Pharmaceuticals, Inc., BioScrip, Inc., VENTRUS BIOSCIENCES INC, Intellicell Biosciences, Inc., CHRONIMED INC, and CITIUS ONCOLOGY, INC..

SEC CIK

Myron Z Holubiak's CIK is 0001199080

Past Insider Trading and Trends

2012 was Myron Z Holubiak's most active year for acquiring shares with 6 total transactions. Myron Z Holubiak's most active month to acquire stocks was the month of May. 2007 was Myron Z Holubiak's most active year for disposing of shares, totalling 15 transactions. Myron Z Holubiak's most active month to dispose stocks was the month of November. 2018 saw Myron Z Holubiak paying a total of $1,009,007.70 for 1,729,043 shares, this is the most they've acquired in one year. In 2013 Myron Z Holubiak cashed out on 62,400 shares for a total of $509,730.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NASTECH PHARMACEUTICAL CO INC (ATRX) No price found

Investor

Myron Z Holubiak owns 15,000 units of Nastech Pharmaceutical Company Common Stock and 26,657 units of Nastech Pharmaceutical Company Inc Common Stock.acquired a total of 44,657 shares in NASTECH PHARMACEUTICAL CO INC, Myron also disposed a total of 3,000 shares of NASTECH PHARMACEUTICAL CO INC equalling to $42,567.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.12%
-3.00K
$14.19
-$42,567.00
26.66K
Aug 15
Form 4
+24.95%
5.92K
—
—
29.66K
Jun 13
Form 4
+31.86%
5.74K
—
—
23.73K
Jun 13
Form 4
+20.00%
3K
—
—
18K
Jul 20
Form 3
—
0
—
—
0
Form 4/A
∞
15K
—
—
15K
Jun 9
Form 4
∞
15K
—
—
15K
Jun 9
No matching records found

Citius Pharmaceuticals, Inc. (CTXR) Snapshot price: $0.54

Vice Chairman

Myron Z Holubiak owns 1,992,243 units of Common Stock which is worth $1,075,811.22. From 2015 to 2024 Myron Z Holubiak acquired a total of 9,229,773 shares in Citius Pharmaceuticals, Inc. at a cost of $1,709,008.12.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Oct 10
Form 4
—
0
—
—
0
Oct 4
Form 4
—
0
—
—
0
Oct 11
Form 4
—
0
—
—
0
Jul 22
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Oct 8
Form 4
+38.96%
558.6K
$0.90
$500,000.17
1.99M
Sep 27
Form 4
+9.93%
129.45K
$1.55
$200,000.25
1.43M
Apr 3
Form 4
—
0
—
—
0
Sep 4
Form 4
+150.86%
784.31K
$1.28
$1,000,000.35
1.3M
Aug 13
Form 4
+0.56%
2.92K
$3.09
$9,007.35
519.88K
Mar 28
Form 4
—
0
—
—
0
Form 4
∞
7.75M
—
—
7.75M
Form 3
—
0
—
—
0
No matching records found

BioScrip, Inc. (OPCH) Snapshot price: $32.1

Investor

Myron Z Holubiak owns 40,000 units of Common Stock, $.0001 par value which is worth $1,284,000.00. In the year 2005 Myron Z Holubiak filed a total of 22 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$2.70
-$27,000.00
40K
May 31
Form 4
—
0
—
—
0
May 20
Form 4
—
0
$6.64
-$13,050.50
40K
Jun 16
Form 4
+33.33%
10K
—
—
40K
May 8
Form 4
-33.33%
-10.00K
$7.23
-$72,259.00
20K
Mar 14
Form 4
—
0
$11.72
-$288,266.00
30K
Scheduled
Jul 19
Form 4
+50.00%
10K
—
—
30K
May 7
Form 4
-33.33%
-10.00K
$10.82
-$108,232.00
20K
Dec 14
Form 4
—
0
$6.40
-$40,580.88
30K
Scheduled
Sep 6 - Sep 7
Form 4
—
0
$6.42
-$28,309.15
30K
Scheduled
Aug 31 - Sep 4
Form 4
+50.00%
10K
$7.52
$75,200.00
30K
May 7
Form 4
-29.82%
-8.50K
$5.43
-$46,141.40
20K
Dec 15
Form 4
+54.05%
10K
—
—
28.5K
Apr 26
Form 4
+37.04%
5K
$6.80
-$34,000.00
18.5K
Jun 15 - Jun 16
Form 4
+58.82%
5K
—
—
13.5K
Apr 28
Form 4
∞
8.5K
—
—
8.5K
Apr 29
Form 4/A
—
0
—
—
0
May 22
Form 4
—
0
$6.54
-$90,383.00
0
Dec 14
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found

VENTRUS BIOSCIENCES INC (ASMB) Snapshot price: $16.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
May 28
Form 4/A
—
0
—
—
0
Jul 10
Form 4/A
—
0
—
—
0
Jul 10
Form 4
—
0
—
—
0
Jul 10
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
Nov 8
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Intellicell Biosciences, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found